Aydin et al. [41] reported that FBXW7 mutational inactivation represents a mechanism for NOTCH1 activation in melanoma and that anti-NOTCH treatment strategies showed promise in reduction of tumor growth in a xenograft model, making the NOTCH pathway a compelling target for therapeutic intervention. The gene discussed is FBXW7; the disease is neoplasm.